Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells

[1]  Y. Nakamura,et al.  Allelotype of colorectal carcinomas. , 1989, Science.

[2]  L. Hartwell,et al.  The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. , 1988, Science.

[3]  P. Gorman,et al.  Distinctive chromosomal structures are formed very early in the amplification of CAD genes in Syrian hamster cells , 1990, Cell.

[4]  A. Fornace,et al.  Induction by ionizing radiation of the gadd45 gene in cultured human cells: lack of mediation by protein kinase C. , 1991, Molecular and cellular biology.

[5]  G Buttin,et al.  Co‐amplified markers alternate in megabase long chromosomal inverted repeats and cluster independently in interphase nuclei at early steps of mammalian gene amplification. , 1992, The EMBO journal.

[6]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[7]  R. W. Jones,et al.  The action of caffeine on X-irradiated HeLa cells. III. Enhancement of X-ray-induced killing during G2 arrest. , 1978, Radiation research.

[8]  B. Mcclintock,et al.  The significance of responses of the genome to challenge. , 1984, Science.

[9]  B. Trask,et al.  Early dihydrofolate reductase gene amplification events in CHO cells usually occur on the same chromosome arm as the original locus. , 1989, Genes & development.

[10]  W. Bigbee,et al.  Evidence for an elevated frequency of in vivo somatic cell mutations in ataxia telangiectasia. , 1989, American journal of human genetics.

[11]  F. Toledo,et al.  The evolution of the amplified adenylate deaminase 2 domains in Chinese hamster cells suggests the sequential operation of different mechanisms of DNA amplification. , 1992, Mutation research.

[12]  T. Tlsty,et al.  Suppression of gene amplification in human cell hybrids. , 1992, Science.

[13]  T. Pandita,et al.  Initial chromosome damage but not DNA damage is greater in ataxia telangiectasia cells. , 1992, Radiation research.

[14]  Bert Vogelstein,et al.  p53 function and dysfunction , 1992, Cell.

[15]  Thea D. Tlsty,et al.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 , 1992, Cell.

[16]  G. Wahl,et al.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles , 1992, Cell.

[17]  B. Vogelstein,et al.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.

[18]  R T Schimke,et al.  Gene amplification in cultured cells. , 1988, The Journal of biological chemistry.

[19]  R. Rowley,et al.  Checkpoint controls in Schizosaccharomyces pombe: rad1. , 1992, The EMBO journal.

[20]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[21]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[22]  J. D. Funkhouser,et al.  Cancer susceptibility in ataxia-telangiectasia. , 1992, Leukemia.

[23]  Brian J. Reid,et al.  Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort , 1992 .

[24]  G. Wahl,et al.  A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. , 1991, Genes & development.

[25]  L. Hartwell,et al.  Checkpoints: controls that ensure the order of cell cycle events. , 1989, Science.

[26]  J. Bedford,et al.  On the nature of a defect in cells from individuals with ataxia-telangiectasia. , 1985, Science.